CompletedNot Applicable

Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface in Intravitreal Injections of Anti-VEGF

Mexico88 participantsStarted 2021-11-15

Plain-language summary

Objective and subjective comparison between the use of povidone-iodine 1% vs 5% as antiseptic in patients that need anti-VEGF intravitreal injection

Who can participate

Age range45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Having anti-VGEF intravitreal injection scheduled * Informed consent signed Exclusion Criteria * Under 45 years * Opacity that prevents ophthalmological evaluation and fixation * Patients with severe dry eye * Patients with signs of infection on the ocular surface * Allergy to iodine * Pregnancy

What they're measuring

Tear breaking rupture

Timeframe: Change from baseline measured to 15 minutes post-injection

Bulbar redness

Timeframe: Change from baseline measured to 15 minutes post-injection

Trial details

NCT IDNCT06710951

SponsorJosé Gerardo García Aguirre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Dry Eye trials